- Home
- ADIL vs DFNS Comparison
ADIL vs DFNS Comparison
Compare ADIL & DFNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADIL | DFNS |
|---|---|---|
| Founded | 2010 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4M | 9.7M |
| IPO Year | 2017 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ADIL | DFNS |
|---|---|---|
| Price | $3.22 | $6.39 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.33 | N/A |
| AVG Volume (30 Days) | 39.2K | ★ 230.7K |
| Earning Date | 11-12-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 261.46 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $5,913,461.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $33.09 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.13 | $3.70 |
| 52 Week High | $9.90 | $335.00 |
Technical Indicators
Market Signals| Indicator | ADIL | DFNS |
|---|---|---|
| Relative Strength Index (RSI) | 29.42 | 38.71 |
| Support Level | $2.38 | $3.70 |
| Resistance Level | $4.94 | $23.45 |
| Average True Range (ATR) | 0.42 | 0.58 |
| MACD | -0.10 | 0.46 |
| Stochastic Oscillator | 1.86 | 41.25 |
Price Performance
Historical ComparisonAbout ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.
About DFNS T3 Defense Inc. Common Stock
T3 Defense Inc is a holding company that acquires and operates mission-critical defense businesses involved in national security programs. The company operates as a strategic platform, building a portfolio of mission-critical suppliers and technology companies. Its portfolio includes businesses involved in defense and aerospace technologies, such as AI software, unmanned aerial systems, electro-mechanical manufacturing, and motion control systems, as well as activities in technology distribution, licensing, and defense infrastructure development through joint ventures.